x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Postscripts Rx

PostScripts Rx Team

Conversations Beyond the Prescription. Where pharma, HCPs, life science and digital health solutions meets patients—after the script is written. Conversations on digital health, engagement, and real-world impacts that are re-writing the future of patient engagement.

health & fitness medicine

All Episodes

11:02

How US Tariffs Are Reshaping UK Pharma Markets

Postscripts Rx ·

2025/09/05

The global pharmaceutical landscape is undergoing a dramatic transformation, with UK pharma feeling the squeeze from US pricing reforms and tariff threats. This episode dives deep into how the 2022 US Inflation Reduction Act has created a domino effect across international markets, forcing companies to make tough strategic choices about pricing and market access. When Eli Lilly temporarily suspended shipments of its blockbuster GLP-1 drug Manjaro to the UK in August, it wasn't due to product...

en-us

20:47

Personalized Patient Engagement: The Future of Pharma

Postscripts Rx ·

2025/09/04

The gap between receiving a prescription and achieving successful treatment outcomes remains one of healthcare's biggest challenges. In this illuminating conversation with Ryan Janvion, VP of Sales and Partnerships at Medisafe, we explore how digital health platforms are revolutionizing patient support after that crucial first prescription. Drawing from his unique background as a college football player at Wake Forest and former Patriots scouting coordinator, Janvion brings a fresh perspecti...

en-us

9:43

Beyond the Prescription: Why Supply Chain Security...

Postscripts Rx ·

2025/09/04

What happens when the medications patients need simply aren't available? The answer is playing out right now across healthcare systems worldwide as pharmaceutical supply chains face unprecedented pressures. The pharmaceutical industry stands at a crossroads as discussions around a potential 200% tariff on imported drug products force executives to confront uncomfortable truths about supply chain vulnerability. With China providing approximately 40% of active pharmaceutical ingredients used i...

en-us

11:10

Amgen's $550M US Investment: Reshaping Pharma's...

Postscripts Rx ·

2025/09/04

Pharmaceutical manufacturing is undergoing a seismic shift, and Amgen's latest $550 million investment in a cutting-edge biotech research facility in California marks a pivotal moment in this transformation. This bold move signals far more than corporate expansion—it represents a fundamental rethinking of how and where medications are developed and produced in a post-pandemic world. The stakes couldn't be higher. When oncology medication supply chains from India were disrupted just two years...

en-us

17:14

When Prices Equalize, Patient Experience Becomes the...

Postscripts Rx ·

2025/08/22

Healthcare is undergoing a pricing revolution that will fundamentally transform how pharmaceutical companies connect with patients. The new Most Favored Nation model means Medicare will soon pay no more than the lowest price pharmaceutical companies charge in other developed nations – a dramatic shift from America's historical position as the world's most lucrative medication market. What happens when price is no longer your competitive advantage? This pivotal moment demands pharmaceutical c...

en-us

7:06

Loneliness Kills: The Surprising Link Between...

Postscripts Rx ·

2025/08/20

Loneliness isn't merely an emotional challenge—it's a clinical emergency hiding in plain sight. The latest research reveals a startling truth: feeling isolated carries the same health risks as smoking 15 cigarettes daily, profoundly impacting medication adherence and treatment outcomes for millions with chronic conditions. A groundbreaking study from Playo and Pure Spectrum uncovers the alarming connection between social isolation and health management. Among 2,000 adults with chronic condit...

en-us

10:21

The September 29th Deadline Is Slipping: What Pharma...

Postscripts Rx ·

2025/08/14

The bumpy road to drug pricing reform continues as the US Most Favored Nation deadline of September 29th faces delays. Regulatory complexities, competing healthcare priorities like the Strategic API Reserve, and election year politics are all contributing factors that may push implementation into 2024 or beyond. • MFN model would force Medicare to pay the lowest drug prices available in other economically comparable countries • Americans currently pay nearly 250% more for medications than ci...

en-us

13:22

Data is the New Currency: Why ROI Matters More Than...

Postscripts Rx ·

2025/08/13

The pharmaceutical industry faces a transformative shift as drug pricing pressures intensify in the US market, with the September 29 deadline approaching for companies to implement Most Favored Nation pricing. Marketing strategies must evolve from traditional branding to outcomes-based approaches that demonstrate real value as margins tighten and price becomes a non-negotiable factor. • Marketing budgets shifting toward outcome-based strategies that demonstrate improved adherence and access ...

en-us

12:51

Counting Down: 47 Days Until Pharma's Pricing Reckoning

Postscripts Rx ·

2025/08/13

The clock is ticking for pharmaceutical companies as the September 29 deadline for most favored nation pricing plans looms just 47 days away. This sweeping policy shift represents one of the most significant pricing reforms in recent history, with profound implications for everyone from brand marketers to patient access teams. Five major developments are converging to reshape the pharmaceutical landscape. First, government price negotiations are accelerating, targeting high-cost drugs withou...

en-us

17:30

Digital Companions for Patient Success

Postscripts Rx ·

2025/08/12

Digital companions are revolutionizing the post-prescription landscape, turning traditional patient support upside down. Cathy Zaremba, Senior Director of Marketing at Medisafe, reveals how personalized, data-driven platforms are transforming medication adherence and patient outcomes through just-in-time interventions. The statistics are sobering: only 50% of patients with chronic conditions adhere to treatments long-term, costing the US healthcare system an estimated $300 billion annually. ...

en-us

8:42

How Digital Companions Drive Pharma ROI in...

Postscripts Rx ·

2025/08/12

The pharmaceutical landscape is shifting dramatically beneath our feet. With the US government recently demanding drug price reductions of up to 60% from major pharma companies or face potential reimbursement restrictions, the industry faces what CNBC calls "one of the most dramatic reshufflings of commercial pharma strategy in decades." This perfect storm – innovation surging while margins tighten – creates urgent questions for pharma marketers, patient support teams, and innovation leaders...

en-us

14:30

Making Health Technology Great Again: What It Means...

Postscripts Rx ·

2025/08/12

The healthcare technology landscape is undergoing a profound transformation with a White House-led initiative dubbed "Make Health Technology Great Again" that aims to create a streamlined approach to health data sharing through a nationwide tracking system. • Accelerated interoperability in health data can transform brand strategies by enabling precision targeting and improved patient engagement • Innovation teams can fast-track development of scalable digital health solutions with fewer tec...

en-us

13:32

How AI Voice Technology Is Transforming...

Postscripts Rx ·

2025/08/12

The healthcare landscape is being reshaped by a powerful new tool: AI voice agents. These conversational companions are addressing one of healthcare's most persistent challenges – medication non-adherence, which affects 50% of patients with chronic conditions and costs the US healthcare system over $300 billion annually. Unlike traditional digital solutions that require technical proficiency, AI voice agents leverage natural conversation to provide timely medication reminders, education, and...

en-us

10:29

From Pizza Apps to Patient Care: The Digital...

Postscripts Rx ·

2025/08/12

Digital health expectations are becoming the new baseline in healthcare as patients increasingly expect the same level of convenience they experience in other aspects of their digital lives. The disconnect between modern consumer expectations and traditional healthcare delivery isn't just frustrating—it can jeopardize treatment outcomes and patient satisfaction. • Over 70% of patients wish healthcare interactions were as easy as online shopping or digital banking • 43% of patients would swit...

en-us

14:39

Digital Marketing and Ai: Cathy Zaremba of Medisafe

Postscripts Rx ·

2025/08/12

Cathy is the Sr. Director of Product Marketing at Medisafe, driving marketing efforts that make patients the center of digital solutions that make a difference. PostScripts Rx is not intended to constitute medical advice, nor is it intended to influence prescribing decisions or any other medical or clinical decision-making. All medical and clinical judgment and decision-making, prescribing decisions, and all related considerations remain exclusively the responsibility of providers and p...

en-us

17:20

Digital Health's Secret: Patient-First Approach

Postscripts Rx ·

2025/08/11

What defines truly effective digital health technology in today's healthcare landscape? According to Brian Carr, SVP of Marketing at Medisafe, the answer is refreshingly straightforward: patient engagement. When seven out of ten users access your platform daily—outperforming even social media giants like Facebook—you know you've created something that genuinely resonates with patients. Medisafe's journey began with a personal crisis when the founder's father accidentally double-dosed o...

en-us

13:01

$50 Billion Pharma Plant Built in Virginia?

Postscripts Rx ·

2025/08/11

PostScripts Rx is not intended to constitute medical advice, nor is it intended to influence prescribing decisions or any other medical or clinical decision-making. All medical and clinical judgment and decision-making, prescribing decisions, and all related considerations remain exclusively the responsibility of providers and patients.

en-us

9:17

What Happens When Drug Imports Cost 250% More?

Postscripts Rx ·

2025/08/08

A seismic shift may be approaching the pharmaceutical industry with US administration statements suggesting pharmaceutical import tariffs could reach a staggering 250 percent. This isn't just another policy headline – it represents a potential transformation of drug pricing, patient access, and brand performance that demands strategic preparation. With approximately 80% of active pharmaceutical ingredients in US medications coming from overseas, these tariffs could trigger multiple cascading...

en-us

38 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown